###begin article-title 0
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-12 RB1</italic>
###xml 41 46 <span type="species:ncbi:9606">Human</span>
IL-12 RB1 Genetic Variants Contribute to Human Susceptibility to Severe Acute Respiratory Syndrome Infection among Chinese
###end article-title 0
###begin p 1
Conceived and designed the experiments: WC WL. Performed the experiments: FT WL MW FZ PZ HY. Analyzed the data: WC FT WL ZX HY HL. Contributed reagents/materials/analysis tools: MW PZ. Wrote the paper: WC FT WL FZ ZX HL.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 118 119 118 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 122 131 122 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-12RB1)</italic>
Cytokines play important roles in antiviral action. We examined whether polymorphisms of interleukin (IL)-12 receptor B1 (IL-12RB1) affect the susceptibility to and outcome of severe acute respiratory syndrome (SARS).
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 110 119 110 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-12 RB1</italic>
###xml 53 61 <span type="species:ncbi:9606">patients</span>
A case-control study was carried out in Chinese SARS patients and healthy controls. The genotypes of 4SNPs on IL-12 RB1 gene, +705A/G,+1158T/C, +1196G/C and +1664 C/T, were determined by PCR-RFLP. Haplotypes were estimated from the genotype data using the expectation-maximisation algorithm.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 19 27 <span type="species:ncbi:9606">patients</span>
###xml 388 396 <span type="species:ncbi:9606">patients</span>
Comparison between patients and close contacts showed that individuals with the +1664 C/T (CT and TT) genotype had a 2.09-fold (95% confidence interval [CI], 1.90-7.16) and 2.34-fold (95% CI, 1.79-13.37) increased risk of developing SARS, respectively. For any of the other three polymorphisms, however, no significant difference can be detected in allele or genotype frequencies between patients and controls. Additionally, estimation of the frequencies of multiple-locus haplotypes revealed potential risk haplotypes (GCCT) for SARS infection.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 43 50 43 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL12RB1</italic>
Our data indicate that genetic variants of IL12RB1confer genetic susceptibility to SARS infection, but not necessary associated with the progression of the disease in Chinese population.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 146 149 146 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002183-Peiris1">[1]</xref>
###xml 279 282 279 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002183-Lau1">[2]</xref>
###xml 407 410 407 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002183-Booth1">[3]</xref>
###xml 412 415 412 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002183-Chan1">[4]</xref>
###xml 579 582 579 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002183-Chiu1">[5]</xref>
###xml 583 587 583 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002183-Chan2">[13]</xref>
###xml 732 735 732 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002183-Chiu1">[5]</xref>
###xml 736 739 736 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002183-Itoyama2">[7]</xref>
###xml 827 831 827 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MBL)</italic>
###xml 872 875 872 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002183-Ip1">[8]</xref>
###xml 877 880 877 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002183-Zhang1">[9]</xref>
###xml 931 935 931 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002183-He1">[10]</xref>
###xml 959 963 959 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002183-Chong1">[11]</xref>
###xml 980 984 980 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002183-Ng1">[12]</xref>
###xml 997 1001 997 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002183-Chan2">[13]</xref>
###xml 80 96 <span type="species:ncbi:227859">SARS coronavirus</span>
###xml 200 216 <span type="species:ncbi:227859">SARS coronavirus</span>
Severe acute respiratory syndrome (SARS) is an infectious disease caused by the SARS coronavirus with >8000 cases and 774 deaths reported in 2003 [1]. Much progress has been made in understanding the SARS coronavirus, but its pathogenesis in infected individuals remains unclear [2]. The early reports showed that old age, diabetes mellitus and heart disease were risk factors for adverse prognosis of SARS [3], [4]. Genetic host factors are as well supposed to play an important role, and polymorphisms in several genes have been tested for their association with the infection [5]-[13]. Three studies have investigated role of angiotensin converting enzyme gene in disease pathogenesis or disease outcome with conflicting results [5]-[7]. Two independent studies displayed the significant role of the mannose-binding lectin (MBL) genetic polymorphisms in SARS infection [8], [9]. Other candidate genes, such as OAS1 and MxA gene [10], interferon gamma gene [11] and RANTES gene [12], ICAM3 gene [13] were also identified in recent studies. A better understanding of these genes will provide new insights into the disease pathogenesis. This knowledge will also aid in identifying the biomarkers for evaluating the efficacy of vaccination and other interventions.
###end p 11
###begin p 12
###xml 90 94 90 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002183-Trinchieri1">[14]</xref>
###xml 531 535 523 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002183-Dorman1">[15]</xref>
###xml 695 699 687 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002183-Cameron1">[16]</xref>
###xml 1114 1120 1106 1112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-12R</italic>
###xml 1273 1279 1265 1271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-12R</italic>
###xml 686 694 <span type="species:ncbi:9606">patients</span>
Interleukin-12 (IL-12) is a cytokine secreted by activated phagocytes and dendritic cells [14]. It plays a pivotal role in promoting Th1-type immune responses and cell-mediated immunity. IL-12 triggers many biological functions: it stimulates the proliferation of activated T- and NK-cells, enhances T- and NK-cell-mediated cytolytic activity, and induces the production of IFN-gamma by both T-and NK-cells (Trinchieri 1998). The interferon-gamma production induced by IL-12 forms a major link between innate and adaptive immunity [15]. A recent study revealed that interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in SARS patients [16]. We thus reasoned that IL-12 might also play a role in resistance to SARS, which is signaled through the direct binding of the IL-12 molecule to its receptor (IL- 12R). IL-12R has been shown to consist of at least two distinct subunits, B1 and B2, that associate to form a high-affinity IL-12R complex expressed on activated T- and NK-cells (17,18). In the current study, we hypothesized that polymorphisms of the IL-12R B1 gene might be associated with SARS susceptibility. To test this hypothesis, we conducted a case control study to investigate the association between IL-12R B1 genetic polymorphisms and SARS in Chinese individuals.
###end p 12
###begin title 13
Materials and Methods
###end title 13
###begin title 14
Cases and controls
###end title 14
###begin p 15
###xml 1063 1067 1063 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002183-WHO1">[19]</xref>
###xml 160 168 <span type="species:ncbi:9606">patients</span>
###xml 291 299 <span type="species:ncbi:9606">patients</span>
###xml 423 431 <span type="species:ncbi:9606">patients</span>
###xml 454 462 <span type="species:ncbi:9606">patients</span>
###xml 820 828 <span type="species:ncbi:9606">patients</span>
###xml 959 967 <span type="species:ncbi:9606">patients</span>
###xml 1159 1167 <span type="species:ncbi:9606">patients</span>
###xml 1287 1295 <span type="species:ncbi:9606">patients</span>
The case and controls were selected from two designated hospitals for SARS in Beijing and Tianjin. During the 2003 SARS epidemic, a total of 132 confirmed SARS patients were reported from these two hospitals, which derived from two completely unrelated super spread events (SSE). All of the patients had been hospitalized for treatment, from which we selected 115 confirmed SARS cases for the study. Three of the remaining patients died and the other 14 patients were unavailable for study, because of the inconvenience of revisiting. The diagnosis was made according to the criteria published by the Chinese Ministry of Public Health, and subsequently confirmed by antibody seroconversion and/or detectable SARS-CoV RNA in respiratory secretions. Two control groups were used, individuals with close contacts with SARS patients (control A) and healthy controls (control B). Control A group consists of 141 subjects who had close contacts with confirmed SARS patients but were not infected, according to criteria that was defined by the World Health Organization [19]. Among these individuals were 110 high-risk health care workers who had been treating SARS patients for a prolonged duration, and 31 individuals who had shared a meal, utensil, residence, ward, vehicle, etc., with SARS patients. Control B group included 155 healthy, unrelated Chinese blood donors, who had blood drawn during July 2001-October 2002. All controls were tested negative for IgG antibody against SARS-CoV prior to being included into the study. All subjects contributed 3ml anti-coagulated blood after written informed consent was obtained. We also used a standard questionnaire to collect demographic information (including age, ethnicity, region of origin, marital status, living environment, education level et al). All subjects were confirmed as genetically unrelated through interviewing. The comorbidity conditions that might have effect on disease susceptibility, such as diabetes mellitus, heart disease, hypertension, asthma, tuberculosis, and malignancy, were traced by reviewing medical records and self reporting. The study protocol was approved by the ethical committee at the National Center for AIDS Prevention and Control.
###end p 15
###begin title 16
IL-12R B1 Genotyping Using PCR-RFLP
###end title 16
###begin p 17
Leucocytes were isolated within 12 h of blood collection using Percoll reagent. Genomic DNA was extracted using cell DNA extraction kit (BioDEV Inc. Beijing, China) following the manufacturer's instructions.
###end p 17
###begin p 18
###xml 112 120 112 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-12RB1</italic>
###xml 126 130 126 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002183-Lee1">[20]</xref>
###xml 393 420 393 420 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ggttaagtgactggtgccaag-3&#8242;</named-content>
###xml 425 452 425 452 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- ctcaaaccactggcctcaag-3&#8242;</named-content>
###xml 500 503 500 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bbv</italic>
###xml 592 618 586 612 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-aacaaacgccatctgctacc-3&#8242;</named-content>
###xml 623 650 617 644 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-caacacctctctgggcctta-3 &#8242;</named-content>
###xml 656 659 650 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hsp</italic>
###xml 735 763 723 751 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; -aacaaacgccatctgctacc-3 &#8242;</named-content>
###xml 768 795 756 783 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-agagtgagaggccacctgag-3 &#8242;</named-content>
###xml 802 805 790 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Msp</italic>
###xml 879 904 861 886 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ggctgtggtagcccagcct-3&#8242;</named-content>
###xml 909 936 891 918 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ggaagcgcagtgcagtgcatg-3&#8242;</named-content>
###xml 967 970 949 952 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bsr</italic>
###xml 1051 1052 1027 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 1067 1068 1043 1044 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 1092 1093 1068 1069 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 1132 1133 1102 1103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 1156 1157 1122 1123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 1180 1183 1146 1149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
We typed the samples for 4 previously reported SNPs that cause missense mutations in the coding sequence of the IL-12RB1 gene [20] , namely +705A/G (Q214R, NCBI SNP ID:rs 11575934), +1158T/C(M365T, NCBI SNP ID:mrs 375947), +1196G/C (G378R, NCBI SNP ID: rs 401502), and +1664 C/T (P534S, HGBASE database ID: SNP001745641). For +705A/G genotyping, genomic DNA was amplified using the primer set 5'-ggttaagtgactggtgccaag-3' and 5'- ctcaaaccactggcctcaag-3'. The PCR fragment obtained was restricted with Bbv I (New England BioLabs, Beverly, Mass., US) at 37degreesC. For +1158T/C typing (M365T), 5'-aacaaacgccatctgctacc-3' and 5'-caacacctctctgggcctta-3 ', and Hsp 92II (Promega, Madison, Wisc., USA) were used at 37degreesC. For +1196G/C, 5' -aacaaacgccatctgctacc-3 ' and 5'-agagtgagaggccacctgag-3 ' , and Msp I (Promega, Madison, Wisc., USA) were used at 37degreesC. For +1664 C/T, 5'-ggctgtggtagcccagcct-3' and 5'-ggaagcgcagtgcagtgcatg-3' were used and restricted with Bsr I (New England BioLabs) at 65degreesC. PCR was carried out in PCR buffer (1.5 m M MgCl 2 , 10 m M Tris-HCl, pH 9.0, 50 m M KCl, 0.1% Triton (R) X-100), 100 microM of each dNTP, 25 microM primers and 1 unit of Taq polymerase in a final volume of 30 microl. Following an initial denaturation at 95degreesC for 5 min, samples were subjected to 30 cycles of PCR amplification with denaturation at 95degreesC for 30 s, annealing at 57-60degreesC for 30 s and elongation at 72degreesC for 30 s, followed by a final elongation step at 72degreesC for 10 min. The reaction products of the PCRs and enzyme restrictions were analyzed on 3% agarose gels (+705A/G, +1158T/C, +1664 C/T) or 8% polyacrylamide gels (+1196G/C). The genotyping of all samples were performed in a blinded manner so that the case or control status was not known. Ten percent of the samples were chosen randomly from each polymorphism for resequencing in order to validate the genotyping method.
###end p 18
###begin title 19
Statistical analysis
###end title 19
###begin p 20
###xml 397 398 397 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 966 970 966 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002183-Nyholt1">[21]</xref>
###xml 996 997 996 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 160 168 <span type="species:ncbi:9606">patients</span>
###xml 376 384 <span type="species:ncbi:9606">patients</span>
Genotype distributions of each SNPs were tested for the Hardy-Weinberg equilibrium by the Chi square test in three groups. The genotype frequencies of the SARS patients and the control subjects were compared, and odds ratios (OR) were calculated by assigning the reference value (1.0) to the homozygous genotype that was more frequent in the control subjects than in the SARS patients. The OR and P values were calculated by multivariate logistic regression analysis with age, sex , comorbidity presence and infection source entered as covariates in the model, given the relevance of these potential confounding variables in interpreting the study results. Data were analyzed using the SPSS software (version 10.0, SPSS Inc, Chicago, IL, USA). To correct for multiple testing, we used spectral decomposition (SpD) of matrices of pairwise linkage disequilibrium (LD) between SNPs, which adjusts for multiple testing while taking into account LD among the tested SNPs [21]. This method showed that P-values of 0.0227 and below can be considered as statistically significant after correction for multiple testing. The software HAPLOVIEW (version 2.05) was used to construct haplotypes from the genotype data. This program calculates association statistics for multilocus haplotypes in case-control data using the expectation- maximisation algorithm to estimate haplotype odds ratios across multiple categories, giving a likelihood ratio test of homogeneity.
###end p 20
###begin title 21
Results
###end title 21
###begin title 22
Baseline Clinical Characteristics of cases and controls
###end title 22
###begin p 23
###xml 0 7 0 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002183-t001">Table 1</xref>
###xml 51 59 <span type="species:ncbi:9606">patients</span>
###xml 229 237 <span type="species:ncbi:9606">patients</span>
###xml 317 325 <span type="species:ncbi:9606">patients</span>
###xml 372 380 <span type="species:ncbi:9606">patients</span>
###xml 567 575 <span type="species:ncbi:9606">patients</span>
Table 1 shows the baseline characteristics of SARS patients and two control groups. The mean age was 33.1+/-11.7 years for SARS cases, 31.6+/-7.0 years for control A group and 28.4+/-11.8 years for control B group. 46.7% of SARS patients, 32.5% of control A group and 71% of control B group were male. Sixty-two SARS patients were health care workers. Thirty-nine (33.9%) patients were classified as a severe group, based on their admissions to intensive care units or deaths due to the disease (mean+/-SD age = 39.45+/-12.8, 20 male and 19 female). The remaining 76 patients were classified as a mild group (mean+/-SD age = 29.61+/-13.5, 46 male and 56 female).
###end p 23
###begin title 24
###xml 40 48 <span type="species:ncbi:9606">patients</span>
The demographic characteristics of SARS patients and controls
###end title 24
###begin title 25
###xml 63 71 <span type="species:ncbi:9606">Patients</span>
Genotype Frequencies of the 4 SNPs of the IL12RB1 gene in SARS Patients and Controls
###end title 25
###begin p 26
###xml 284 292 <span type="species:ncbi:9606">patients</span>
The Hardy-Weinberg equilibrium test based on the genotype frequency was carried out separately for the three groups of individuals. For control B group, the genotype distributions of the 4 SNPs (+705A/G, +1158T/C, +1196G/C and +1664 C/T) were in Hardy-Weinberg equilibrium, while for patients group, the genotype distribution of +1664 C/T polymorphisms deviate slightly from Hardy-Weinberg equilibrium (data not shown).
###end p 26
###begin p 27
###xml 259 266 259 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002183-t002">Table 2</xref>
###xml 396 397 396 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 432 433 432 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 523 524 523 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 53 61 <span type="species:ncbi:9606">patients</span>
###xml 337 345 <span type="species:ncbi:9606">patients</span>
###xml 690 698 <span type="species:ncbi:9606">patients</span>
The genotyping results were missing from some of the patients, because the DNA samples were not enough for all of the loci detection, or the poor RFLP results, which led to their exclusion from the analysis. Allele frequencies at the four loci were compared (Table 2). +1664 C/T (T) allele is shown to be overrepresented in the group of patients, when compared with those in the control A group (P-value 0.044) and control B group (P-value 0.056). However, when the Nyholt correction was applied in the screening step, the P values turned out to be not significant. The allele frequencies of the other three SNPs (+705A/G, +1158T/C, +1196 G/C) were not significantly different between SARS patients and any of the two control groups, with all the P value to be great than 0.05.
###end p 27
###begin title 28
###xml 26 35 26 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-12 RB1</italic>
###xml 87 95 <span type="species:ncbi:9606">patients</span>
Allele frequencies of the IL-12 RB1 705A/G, 1158T/C, 1196G/C and 1664 C/T SNPs in SARS patients and controls
###end title 28
###begin p 29
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
P-value and OR (95% CI) were calculated with the use of logistic regression models, adjusted with sex, age, comorbidity presence and infection source.
###end p 29
###begin p 30
OR = Odds ratio; CI = confidence interval;
###end p 30
###begin p 31
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 31 32 31 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 5 13 <span type="species:ncbi:9606">Patients</span>
###xml 33 41 <span type="species:ncbi:9606">Patients</span>
OR a Patients VS Control A ; ORb Patients VS Control B.
###end p 31
###begin p 32
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 7 8 7 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 33 34 33 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 40 41 40 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 9 17 <span type="species:ncbi:9606">Patients</span>
###xml 42 50 <span type="species:ncbi:9606">Patients</span>
P valuea Patients VS Control A ; P valueb Patients VS Control B.
###end p 32
###begin p 33
###xml 47 54 47 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002183-t003">Table 3</xref>
###xml 178 179 178 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 500 502 500 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CI</italic>
###xml 122 130 <span type="species:ncbi:9606">patients</span>
###xml 265 273 <span type="species:ncbi:9606">patients</span>
###xml 613 621 <span type="species:ncbi:9606">patients</span>
###xml 686 694 <span type="species:ncbi:9606">patients</span>
###xml 923 931 <span type="species:ncbi:9606">patients</span>
Genotype frequencies at four loci are shown in Table 3. A significant difference in the genotype frequencies between SARS patients and controls was found for the +1664 C/T SNPs (P<0.001). The +1664 C/T (CT) and (TT) genotypes were significantly over represented in patients (41.5% and 8.5%, respectively) than in control A group (29.5% and 4.5%, respectively). Compared to the CC genotype, CT and TT genotypes were found to be associated with increased susceptibility to SARS infection with ORs (95% CI) of 2.09 (1.90-7.16) and 2.34 (1.79-13.37), respectively. The genotype analysis of the +1664 C/T between SARS patients and control A group yielded different result with those between patients and control B group, when the control B group were compared, no difference of the genotype distribution can be detected. Genotype frequencies of +705 A/G, +1158T/C or +1196 G/C SNPs were not significantly different between SARS patients and each of the two control groups.
###end p 33
###begin title 34
###xml 24 33 24 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-12 RB1</italic>
###xml 85 93 <span type="species:ncbi:9606">patients</span>
Genotype frequencies of IL-12 RB1 705A/G, 1158T/C, 1196G/C and 1664 C/T SNPs in SARS patients and controls groups
###end title 34
###begin p 35
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
P-value and OR (95% CI) were calculated with the use of logistic regression models, adjusted with sex, age, comorbidity presence and infection source.
###end p 35
###begin p 36
OR = Odds ratio; CI = confidence interval;
###end p 36
###begin p 37
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 31 32 31 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 5 13 <span type="species:ncbi:9606">Patients</span>
###xml 33 41 <span type="species:ncbi:9606">Patients</span>
OR a Patients VS Control A ; ORb Patients VS Control B.
###end p 37
###begin p 38
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 7 8 7 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 33 34 33 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 40 41 40 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 9 17 <span type="species:ncbi:9606">Patients</span>
###xml 42 50 <span type="species:ncbi:9606">Patients</span>
P valuea Patients VS Control A ; P valueb Patients VS Control B.
###end p 38
###begin p 39
###xml 12 13 12 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Significant P value after correction by Nyholt method
###end p 39
###begin title 40
Association between genotype frequencies of the 4 SNPs and the severity of SARS
###end title 40
###begin p 41
###xml 629 630 629 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 5 13 <span type="species:ncbi:9606">patients</span>
###xml 118 126 <span type="species:ncbi:9606">patients</span>
###xml 488 496 <span type="species:ncbi:9606">patients</span>
SARS patients were then divided into two subgroups according to the severity of the disease: advanced subgroup (i.e., patients with moderate or advanced lung disease) and mild subgroup. Multiple regression models were re-established for each SNP, with age, sex and the source of infection hospital as covariates. Association with the severity of SARS infection was then estimated by comparing the genotype frequencies and allele frequencies of all the SNPs between the two groups of SARS patients. The final model building disclosed prominent associations between advanced disease with carrying +1664 C/T (CT) and (TT) genotype (P = 0.037). However, this was found not to be significant after Nyholt correction was applied to the analysis. Again, there were no significant differences in the genotype and allele distributions of the +705 A/G , +1158T/C or +1196 G/C SNPs between those with mild disease and those with advanced disease (data not shown).
###end p 41
###begin title 42
Haplotype analysis
###end title 42
###begin p 43
###xml 266 273 266 273 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">A-T-G-C</named-content>
###xml 299 306 299 306 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">G-C-C-T</named-content>
###xml 589 596 589 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002183-t004">Table 4</xref>
###xml 615 619 615 619 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GCCT</named-content>
###xml 638 646 <span type="species:ncbi:9606">patients</span>
###xml 857 865 <span type="species:ncbi:9606">patients</span>
Pairwise linkage disequilibrium (LD) analysis of the four SNPs showed strong LD among +705 A/G, +1158T/C and +1196G/C SNPs (D' = 0.90-0.98) and modest LD value between +1664 C/T and one of the other three SNPs (D' = 0.64-0.81), thus revealing two common haplotypes (A-T-G-C (705-1158-1196-1664) and G-C-C-T). To investigate if a particular haplotype constituted by these SNPs was associated with the disease, haplotype frequencies were estimated and association analysis was performed using multiple logistic regression with age, sex and infection source being the covariants. As shown in Table 4, the frequency of GCCT haplotype in SARS patients (26.6%) was significantly increased when compared to the control A group (11.1%), but when compared to the control B group, the proportions of this haplotype in the two groups were not different (26.6% in SARS patients vs. 22.3% in controls).
###end p 43
###begin title 44
###xml 97 106 97 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-12 RB1</italic>
###xml 115 123 <span type="species:ncbi:9606">patients</span>
Estimated frequencies of haplotypes constituted by 705A/G, 1158T/C, 1196G/C and 1664 C/T SNPs of IL-12 RB1 in SARS patients and controls
###end title 44
###begin p 45
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
P-value and OR (95% CI) were calculated with the use of logistic regression models, adjusted with sex, age, comorbidity presence and infection source.
###end p 45
###begin p 46
OR = Odds ratio; CI = confidence interval;
###end p 46
###begin p 47
###xml 6 14 <span type="species:ncbi:9606">Patients</span>
OR of Patients VS ControlA ;
###end p 47
###begin p 48
###xml 6 14 <span type="species:ncbi:9606">Patients</span>
OR of Patients VS Control B.
###end p 48
###begin p 49
Haplotypes with frequencies <5%.
###end p 49
###begin p 50
###xml 12 13 12 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Significant P value after correction by Nyholt method
###end p 50
###begin title 51
Discussion
###end title 51
###begin p 52
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-12R</italic>
###xml 154 158 154 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002183-Fieschi1">[22]</xref>
###xml 159 163 159 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002183-StaretzHaham1">[24]</xref>
###xml 375 384 375 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-12 RB1</italic>
###xml 565 570 565 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL12R</italic>
###xml 574 575 571 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</italic>
###xml 860 864 857 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002183-Sakai1">[25]</xref>
###xml 1145 1154 1142 1151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-12 RB1</italic>
###xml 1239 1243 1236 1240 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GCCT</named-content>
###xml 1467 1471 1464 1468 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GCCC</named-content>
###xml 1521 1527 1518 1524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL12B1</italic>
###xml 100 117 <span type="species:ncbi:10407">hepatitis B virus</span>
###xml 398 406 <span type="species:ncbi:9606">patients</span>
###xml 1014 1022 <span type="species:ncbi:9606">patients</span>
###xml 1098 1106 <span type="species:ncbi:9606">patients</span>
IL-12R has previously been reported to be associated with infectious diseases such as tuberculosis, hepatitis B virus infection, and parvovirus infection [22]-[24], revealing its potential role of function in host defense against microbial infections. We genotyped 4 SNPs (+705A/G, +1158T/C , +1196G/C and +1664 C/T) that have been alleged to cause missense mutations of the IL-12 RB1 gene in SARS patients , close contacts and healthy controls. These four SNPs (one novel) have been confirmed to cause missense variants in the extracellular coding sequence of the IL12RBeta1gene. These four SNPs lie within 6.2-kb span of genomic DNA on chromosome 19p13.1. It is suggested that one or more of the four missense variants could affect the quality (or quantity) of the gene products and cause mild functional impairment in the receptor's responsiveness to IL-12 [25]. The results show that individuals with 1664 C/T (CT) and (TT) genotype were at increased risk of susceptibility to SARS infection. When only severe patients were considered, the significance disappeared, in comparison with the mild patients. We also estimated the frequencies of IL-12 RB1 haplotypes, which composed of 4 polymorphic alleles, and identified risk haplotype (GCCT) that might confer genetic susceptibility to SARS infection. In agreement with this finding, the +1664 C/T (T) allele was among the risk haplotypes GCCT, whereas the alternative C allele was among the protective haplotype (GCCC). These findings support the association between IL12B1 polymorphism and SARS infection, but not necessary the disease outcome in Chinese population.
###end p 52
###begin p 53
###xml 747 751 747 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002183-Leal1">[26]</xref>
###xml 657 665 <span type="species:ncbi:9606">patients</span>
It is interesting to note that these associations only exist when close contacts were used as a control group. When healthy blood donors were used as controls, no association could be detected. We reasoned that genetic difference between the two control groups might partly account for the distinct observations with regard to SARS susceptibility, i.e. close contacts might be more immunogenetically resistant to SARS infection than healthy controls. In this case, close contacts might serve as more suitable controls healthy individuals, who had never been exposed to SARS-CoV. It's as well intriguing that the pattern of polymorphism in +1664 C/T in SARS patients deviated slightly from Hardy-Weinberg equilibrium. As noted in the previous study[26], detection of HW disequilibrium at SNP loci in the case sample could be an indicator that a disease/susceptibility gene is within the region. There are also other possibilities indicated, like that a pseudo-SNP is present, DNA contamination, or a genotyping error, however, these latter possibilities are unlikely since we have duplicated the genotyping assay for all the samples with ambiguous results through sequencing. This also can be argued from the observed perfect adherence to Hardy-Weinberg disequilibrium from control group. The chance of subgroup is minor, since all the subjects were Chinese Han population without consanguineous relationship. Taken together, we suggested this deviation was from the correlation between genetic variant and disease, instead of false association.
###end p 53
###begin p 54
###xml 335 338 335 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002183-Chiu1">[5]</xref>
###xml 340 343 340 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002183-Itoyama2">[7]</xref>
###xml 1174 1177 1174 1177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002183-Booth1">[3]</xref>
###xml 1179 1182 1179 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002183-Chan1">[4]</xref>
###xml 551 557 <span type="species:ncbi:9606">humans</span>
###xml 568 576 <span type="species:ncbi:9606">patients</span>
###xml 750 758 <span type="species:ncbi:9606">patients</span>
SARS pathogenesis is less well understood, yet it is a vital issue in the disease management. It has been suggested that genetic variations of the host and/or the virus may account for the individual difference in the severity of the disease. Studies have addressed some of the host genes that might play a role in disease development [5], [7]. However, all of the available studies have failed to take viral factor(s) into consideration. These studies thus cannot exclude the possible false association caused by the differentiated viral adaption in humans. The SARS patients in the current study were mostly health care workers in two SARS-designated hospitals. Epidemiological investigations have clearly defined detailed transmission among those patients, showing each of the group came from one super spread chain arising from one infection source. In the multiple logistic analysis, we used the infection source as one of the covariants, and by doing so, we could technically exclude the potential confounding effect that might be caused by viral factor(s). Advanced age and presence of comorbidity are other two factors that might influence the disease susceptibility[3], [4], which were excluded from potential confounding by multiple variants analysis.
###end p 54
###begin p 55
###xml 403 410 <span type="species:ncbi:9606">patient</span>
###xml 758 763 <span type="species:ncbi:9606">human</span>
###xml 1232 1239 <span type="species:ncbi:9606">patient</span>
It should be mentioned not all of the subjects were genotyped due to the inadequacy of DNA samples. Especially for the +C1664T SNP, different percentages of genotypes were missing from SARS, Control A, and Control B groups (18.2%, 6.4% and 3.2% respectively). One can reasonably argue there was another SNP that accounted for the increased fraction of subjects without the defined genotypes in the SARS patient group. It can also be argued that the significant SNPs actually are not functional variants of the IL-12RB1 protein, but instead it is presumably in linkage disequilibrium with a potential functional variant(s) in other loci of the gene. Presently 15 coding, nonsynonymous SNPS are listed in the Entrez database dbSNP, out of a total of 274 known human SNPs for IL12RB1, however, the genotyping for other SNPs in small group of the current population showed MAF (minor allele frequency) of less than 5% (unpublished data). We thus propose the lack of a complete analysis of the SNPS in this gene can pose no severe damage to the study. Still we could not formally exclude possible additional causal variation(s) elsewhere in the gene. The sequencing of the exon and the promoter regions of the IL12RB1 gene from the SARS patient cohort could be helpful in identifying other SNPs which could alter the gene expression level. It would also be warranted to examine whether the same association is observed in other ethnic groups. On the other hand, a relatively small sample size inevitably resulted in limitations of the power to detect significant association in disease outcome. As such, the negative results on SNPs for disease outcome revealed in this study do not necessarily exclude their association with SARS.
###end p 55
###begin p 56
###xml 134 138 134 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002183-Wong1">[27]</xref>
###xml 251 255 247 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002183-Kennedy1">[28]</xref>
###xml 257 261 253 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002183-Manetti1">[29]</xref>
###xml 455 459 451 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002183-VanReeth1">[30]</xref>
###xml 67 75 <span type="species:ncbi:9606">patients</span>
In one previous study, marked elevation of IL-12 in plasma of SARS patients had been observed for at least 2 weeks after disease onset[27], Since IL-12 can induce the production of IFN-gamma and other Th1 cytokines with suppression of the Th2 pathway [28], [29].the observed early elevation of IL-12 could be causative of the SARS-CoV-induced activation of Th1 cells and NK cells, release of chemokines such as IL-8, and results in pulmonary inflammation [30]. One could then hypothesize that decreased IL-12R activity might predispose to infection but protect from severe disease manifestations. However, the data presented here appear to suggest that IL-12R activity is required for protection from severe disease, although the association between genetic polymorphisms and severe disease was no longer significant after multiple test correction was applied to the analysis. Therefore the actual role of IL12 in the protection from or susceptibility to severe disease still need more evidence from animal experiments.
###end p 56
###begin p 57
###xml 53 62 53 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-12 RB1</italic>
In summary, our data support the association between IL-12 RB1 polymorphism and SARS. These genetic variations might predispose individuals to SARS infection by diminishing receptor responsiveness to IL-12, leading to partial dysfunction of interferon-gamma-mediated immunity. Further genetic and biologic studies of these genetic variants could also render valuable insights into SARS susceptibility and pathogenesis.
###end p 57
###begin p 58
###xml 20 28 <span type="species:ncbi:9606">patients</span>
We thank all of the patients and the health-care workers who participated in the present study.
###end p 58
###begin title 59
References
###end title 59
###begin article-title 60
Severe acute respiratory syndrome.
###end article-title 60
###begin article-title 61
Pathogenesis of severe acute respiratory syndrome.
###end article-title 61
###begin article-title 62
###xml 49 57 <span type="species:ncbi:9606">patients</span>
Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area.
###end article-title 62
###begin article-title 63
Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS).
###end article-title 63
###begin article-title 64
ACE2 gene polymorphisms do not affect outcome of severe acute respiratory syndrome.
###end article-title 64
###begin article-title 65
Identification of an alternative 5'-untranslated exon and new polymorphisms of angiotensin-converting enzyme 2 gene: lack of association with SARS in the Vietnamese population.
###end article-title 65
###begin article-title 66
ACE1 polymorphism and progression of SARS.
###end article-title 66
###begin article-title 67
###xml 26 71 <span type="species:ncbi:227859">severe acute respiratory syndrome coronavirus</span>
Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection.
###end article-title 67
###begin article-title 68
###xml 84 129 <span type="species:ncbi:227859">severe acute respiratory syndrome coronavirus</span>
Association between mannose-binding lectin gene polymorphisms and susceptibility to severe acute respiratory syndrome coronavirus infection.
###end article-title 68
###begin article-title 69
Association of SARS susceptibility with single nucleic acid polymorphisms of OAS1 and MxA genes: a case-control study.
###end article-title 69
###begin article-title 70
The interferon gamma gene polymorphism +874 A/T is associated with severe acute respiratory syndrome.
###end article-title 70
###begin article-title 71
The association of RANTES polymorphism with severe acute respiratory syndrome in Hong Kong and Beijing Chinese.
###end article-title 71
###begin article-title 72
Association of ICAM3 genetic variant with severe acute respiratory syndrome.
###end article-title 72
###begin article-title 73
Proinflammatory and immunoregulatory functions of interleukin-12.
###end article-title 73
###begin article-title 74
###xml 56 61 <span type="species:ncbi:9606">human</span>
Interferon-gamma and interleukin-12 pathway defects and human disease.
###end article-title 74
###begin article-title 75
###xml 115 123 <span type="species:ncbi:9606">patients</span>
Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome.
###end article-title 75
###begin article-title 76
###xml 24 29 <span type="species:ncbi:9606">human</span>
Expression cloning of a human IL-12 receptor component: a new member of the cytokine receptor superfamily with strong homology to gap130.
###end article-title 76
###begin article-title 77
IL12 receptors and receptor antagonists.
###end article-title 77
###begin article-title 78
Case definitions for surveillance of severe acute respiratory syndrome (SARS).
###end article-title 78
###begin article-title 79
Lack of an Association between Interleukin-12Receptor B1 Polymorphisms and Tuberculosis in Koreans.
###end article-title 79
###begin article-title 80
A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other.
###end article-title 80
###begin article-title 81
Low penetrance, broad resistance, and favorable outcome of Interleukin 12 receptor B1 deficiency: medical and immunological implications.
###end article-title 81
###begin article-title 82
Clinical tuberculosis in 2 of 3 siblings with interleukin-12 receptor B1 deficiency.
###end article-title 82
###begin article-title 83
Interleukin-12 receptor B1 deficiency presenting as recurrent Salmonella infection.
###end article-title 83
###begin article-title 84
###xml 116 143 113 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium avium complex</italic>
###xml 116 143 <span type="species:ncbi:37162">Mycobacterium avium complex</span>
Missense mutation of interleukin-12 receptor beta1 chain-encoding gene is associated with impaired immunity against Mycobacterium avium complex infection.
###end article-title 84
###begin article-title 85
Detection of genotyping errors and pseudo-SNPs via deviations from Hardy-Weinberg equilibrium.
###end article-title 85
###begin article-title 86
Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome.
###end article-title 86
###begin article-title 87
Interleukin-12 regulates the proliferation of Th1, but not Th2 or Th0, clones.
###end article-title 87
###begin article-title 88
###xml 108 113 <span type="species:ncbi:9606">human</span>
Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFNgamma production in established Th2 cell clones.
###end article-title 88
###begin article-title 89
###xml 82 87 <span type="species:ncbi:9823">swine</span>
In vivo studies on cytokine involvement during acute viral respiratory disease of swine: troublesome but rewarding.
###end article-title 89
###begin p 90
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 90
###begin p 91
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by the grants from the National Science Fund for Distinguished Scholars (No. 30725032) and the Commission of the European Community, as part of the project "Effective and Acceptable Strategies for the Control of SARS and New Emerging Infections in China and Europe" (Contract No. 003824). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 91

